Pacira BioSciences, Inc. (PCRX) — Cash Flow Quality Index
Pacira BioSciences, Inc. (PCRX) has a Cash Flow Quality Index of 12.35x as of June 2026. Operating cash flow of $57.46 Million exceeds net income of $4.65 Million, indicating high earnings quality where cash backs reported profits. Explore PCRX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pacira BioSciences, Inc. Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Pacira BioSciences, Inc. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Pacira BioSciences, Inc..
Annual Cash Flow Quality Index for Pacira BioSciences, Inc. (2015–2025)
Year-by-year earnings quality comparison for Pacira BioSciences, Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 21.61x | $151.99 Million | $7.03 Million | ▲ +486.2% |
| 2023 | 3.69x | $154.65 Million | $41.95 Million | ▼ -59.6% |
| 2022 | 9.13x | $145.27 Million | $15.91 Million | ▲ +204.9% |
| 2021 | 2.99x | $125.72 Million | $41.98 Million | ▲ +465.7% |
| 2020 | 0.53x | $77.03 Million | $145.52 Million | ▼ -96.6% |
| 2015 | 15.62x | $29.00 Million | $1.86 Million | — |